Application 206432

Type: ANDA
Sponsor: CADILA PHARMS LTD

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	NATEGLINIDE	NATEGLINIDE	TABLET;ORAL	60MG	No	No
002	NATEGLINIDE	NATEGLINIDE	TABLET;ORAL	120MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A206432-001	NATEGLINIDE	NATEGLINIDE	60MG	TABLET / ORAL	AB		2019-04-19
A206432-002	NATEGLINIDE	NATEGLINIDE	120MG	TABLET / ORAL	AB		2019-04-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A206432-001	AB
A206432-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206432-001	NATEGLINIDE	60MG	TABLET / ORAL	AB	2019-04-19	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A206432-002	NATEGLINIDE	120MG	TABLET / ORAL	AB	2019-04-19	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A206432-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206432-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206432-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206432-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206432-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206432-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206432-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206432-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206432-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206432-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206432-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206432-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206432-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206432-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206432-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206432-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206432-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206432-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206432-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206432-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206432-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206432-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206432-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206432-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206432-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206432-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206432-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206432-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206432-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A206432-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206432-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206432-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206432-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A206432-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206432-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A206432-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206432-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A206432-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206432-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A206432-002	AB	1	`bb7c543d1eb4…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Nateglinide	NATEGLINIDE	Cadila Pharmaceuticals Limited	c678b772-acba-4b59-a0b2-d70d84283425	2022-12-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206432 application number: ANDA206432 ndc (product): 71209-030 ndc (product): 71209-031
Nateglinide	NATEGLINIDE	Modavar Pharmaceuticals LLC	af81465b-5f49-4eeb-8122-ef7fe5d90ddc	2021-08-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206432 application number: ANDA206432 ndc (product): 72241-002 ndc (product): 72241-003
NATEGLINIDE	NATEGLINIDE	Nivagen Pharmaceuticals, Inc.	21b211b5-cc92-490f-9903-42fff6a946cd	2021-01-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206432 application number: ANDA206432 ndc (product): 75834-206 ndc (product): 75834-205

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 16 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
71209-030	Nateglinide	Nateglinide	Cadila Pharmaceuticals Limited	ANDA	Current
71209-030	Nateglinide	Nateglinide	Cadila Pharmaceuticals Limited	ANDA	Current
71209-030	Nateglinide	Nateglinide	Cadila Pharmaceuticals Limited	ANDA	Current
71209-030	Nateglinide	Nateglinide	Cadila Pharmaceuticals Limited	ANDA	Current
71209-030	Nateglinide	Nateglinide	Cadila Pharmaceuticals Limited	ANDA	Current
71209-031	Nateglinide	Nateglinide	Cadila Pharmaceuticals Limited	ANDA	Current
71209-031	Nateglinide	Nateglinide	Cadila Pharmaceuticals Limited	ANDA	Current
71209-031	Nateglinide	Nateglinide	Cadila Pharmaceuticals Limited	ANDA	Current
71209-031	Nateglinide	Nateglinide	Cadila Pharmaceuticals Limited	ANDA	Current
71209-031	Nateglinide	Nateglinide	Cadila Pharmaceuticals Limited	ANDA	Current
72241-002	Nateglinide	Nateglinide	Modavar Pharmaceuticals LLC	ANDA	Current
72241-003	Nateglinide	Nateglinide	Modavar Pharmaceuticals LLC	ANDA	Current
75834-205	NATEGLINIDE	NATEGLINIDE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-205	NATEGLINIDE	NATEGLINIDE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-206	NATEGLINIDE	NATEGLINIDE	Nivagen Pharmaceuticals, Inc.	ANDA	Current
75834-206	NATEGLINIDE	NATEGLINIDE	Nivagen Pharmaceuticals, Inc.	ANDA	Current